It's not just toxicity that gets you

You may remember the hubbub about four years ago, when it emerged that antidepressants can cause suicidal thoughts in kids. After investigating the issue, the FDA ordered companies to place a "black box" warning noting suicidality as a potential side effect of the medication. But antidepressants aren't the only drugs that can cause psychiatric problems. The New York Times linkurl:reported;http://www.nytimes.com/2008/01/24/washington/24fda.html?ref=health&pagewanted=print yesterday (January 2

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
You may remember the hubbub about four years ago, when it emerged that antidepressants can cause suicidal thoughts in kids. After investigating the issue, the FDA ordered companies to place a "black box" warning noting suicidality as a potential side effect of the medication. But antidepressants aren't the only drugs that can cause psychiatric problems. The New York Times linkurl:reported;http://www.nytimes.com/2008/01/24/washington/24fda.html?ref=health&pagewanted=print yesterday (January 24) that the agency is now going to demand that companies making drugs for treating conditions such as obesity, urinary incontinence, epilepsy and smoking cessation, as well as linkurl:depression,;http://www.the-scientist.com/article/display/52980/ include a suicide assessment in their clinical trials. FDA researchers created a questionnaire that is becoming a mandatory part of some drug testing. Apparently, because of its level of detail, its use is so popular that it has been translated into 80 languages. The belief used to be that drugs that don't reach the brain have no effect on the mind. But it turns out that isn't true. That's because a drug can affect peripheral processes, which can in turn change brain chemistry, Dr. Thomas R. Insel, director of the National Institute of Mental Health, told the Times. The article lists a long string of medicines, treating everything from hypertension to bacterial infections, that have been found to cause psychiatric problems.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies